SONOSITE LX ULTRASOUND SYSTEM (AMBIS 2183401)

This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 - Streamlined Procedures for Evaluation and solicitation for commercial Items, as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-NIAID-24-2183401 and the solicitation is issued as a Request for Quotes (RFQ). This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2024-05 dated May 22, 2024. The North American Industry Classification System (NAICS) code for this procurement is 334510, Electromedical and Electrotherapeutic Apparatus Manufacturing, with a small business size standard of 1,250 employees. The requirement is being competed with a brand name restriction, and without a small business set-aside. The National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), Division of Intramural Research (DIR), Laboratory of Clinical Immunology and Microbiology (LCIM), Infectious Disease Consult Service, provides clinical supervision and training of infectious disease fellows and of residents and medical students rotating on the Infectious Disease Consult Service at the NIH. The Infectious Disease Consult Service has a current requirement for a Sonosite LX ultrasound device. The Sonosite LX ultrasound device will improve the care provided by the Infectious Diseases Consult Service, leading to better outcomes for patients. It will enable more accurate diagnoses, which in turn will help develop more comprehensive treatment plans. The device will be used in a training setting to enhance the physical examination of immunosuppressed patients who may not exhibit obvious signs of infection during a regular exam. By using the Sonosite LX, consultants will be better equipped to identify early indicators of infection, allowing for earlier interventions and improved patient care. The Sonosite LX offers: 1)ultrasound voice assist that allows you to control key?commands being hands-free allowing you to control the system from across the bed of patient all while maintaining a clean or sterile environment, 2) image clarity on a large, adaptable clinical display for easy viewing with clinical team members and consultation with patients, 3) the T8-3 transesophageal transducer that allows clinicians to confidently assess patients during cardiac exams, resuscitation, and monitoring during surgery, 4) a small footprint, rotating and extending display, and vertically adjustable control panel to gain optimal bedside access, and 5) cleaning mode to improve ease of infection control between procedures Both attending physicians and fellows will be trained on this device, with the goal of utilizing it in future research protocols as well. The National Institute of Allergy and Infectious Diseases (NIAID) has a requirement for the following Brand Name Supplies: Sonosite LX Ultrasound System, part # L28354, quantity 1 Transducer, C5-1, part # L23119, quantity 1 Transducer, L12-3, part # L22916, quantity 1 Transducer, P5-1, part # L24087, quantity 1 Sonosite USB Bar Code Scanner, part # L25250, quantity 1 Place of Performance: NIH, 9000 Rockville Pike, Building 10, Bethesda, MD 20892, United States. FOB: Destination Delivery: Delivery estimate is 45 days after receipt and acceptance of award. The government intends to award a firm fixed price purchase order to the responsible contractor as a result of this RFQ that will include the terms and conditions set forth herein. The award will be based on the following: technical capability to meet the requirements, price, and delivery. By submitting a quote in response to this solicitation, vendor is accepting the following terms and conditions: The following FAR provisions apply to this acquisition: FAR 52.212-1 Instructions to Offerors Commercial Items (SEP 2023) FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (MAY 2024) FAR 52.204-7 System for Award Management (OCT 2018) (Offerors must complete annual representations and certifications on-line at http://www.sam.gov/ in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items (Please ensure FAR 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Nov 2015) is updated in your SAM record) FAR 52.203-18 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements - Representation (JAN 2017) FAR 52.204'26 Covered Telecommunications Equipment or Services-Representation (OCT 2020) *** Must complete representation if attached to this solicitation- see attachment 52.204-26 The following FAR contract clauses apply to this acquisition: FAR 52.212-4 Contract Terms and Conditions Commercial Items (NOV 2023) FAR 52.212-5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (MAY 2024) *The applicable subparagraphs of FAR52.212-5 are included in the attachment to this posting. FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (MAR 2023) FAR 52.204-13 System for Award Management Maintenance (OCT 2018) FAR 52.204-25 Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment (NOV 2021) HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (December 2015) FAR 52.252-2 -- Clauses Incorporated by Reference. (Feb 1998) This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this address: http://farsite.hill.af.mil/vffara.htm By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov). Copies of the above-referenced provisions and clauses are available from http://www.acquisition.gov/far/loadmainre.html & http: //www.hhs.gov/regulation/index.html or, upon request, either by telephone or fax. Submission shall be received not later than June 10, 2024 @ 4:00 PM EST Offers may be e-mailed to Rita Davis (contact@example.gov). Offers shall include RFQ number in the subject line (RFQ-NIAID-24-2183401). Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f). All responsible sources may submit an offer that will be considered by this Agency. Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to Rita Davis @ contact@example.gov.